RNA splicing is highly dysregulated in cancers, creating novel opportunities for therapeutic intervention by targeting key nodes of the RNA processing pathway. Marlinspike Therapeutics has developed a functional genomics and computational biology platform to identify cancers that are vulnerable to targeting RNA splicing and define molecular targets that exploit these vulnerabilities. In addition to tumor-intrinsic dependencies, recent work from o...
About Us. RNA splicing is highly dysregulated in cancers, creating novel opportunities for therapeutic intervention by targeting key nodes of the RNA processing pathway. Marlinspike Therapeutics has developed a functional genomics and computational biology platform to identify cancers that are vulnerable to targeting RNA splicing and define molecular targets that exploit these vulnerabilities. In addition to tumor-intrinsic dependencies, exciting...
RNA splicing is highly dysregulated in cancers, creating novel opportunities for therapeutic intervention by targeting key nodes of the RNA processing pathway. Marlinspike Therapeutics has developed a functional genomics and computational biology platform to identify cancers that are vulnerable to targeting RNA splicing and define molecular targets that exploit these vulnerabilities. In addition to tumor-intrinsic dependencies, recent work from o...
RNA splicing is highly dysregulated in cancers, creating novel opportunities for therapeutic intervention by targeting key nodes of the RNA processing pathway. Marlinspike Therapeutics has developed a functional genomics and computational biology platform to identify cancers that are vulnerable to targeting RNA splicing and define molecular targets that exploit these vulnerabilities. In addition to tumor-intrinsic dependencies, recent work from o...
